Revenues from the India business rose by a marginal 3% to Rs 34,901 crore for the quarter under review. India’s EBITDA was at Rs 7,514 crore, a decline of 22%. This translates into EBITDA per ton of Rs 15,651 and a margin of 22%.
AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug Durvalumab
AstraZeneca Pharma Share Price: The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages (SMAs).